Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionCozad Asset Management Inc
Latest Disclosed Ownership6,363 shares
Latest Disclosed Value $ 385,916
Cozad Asset Management Inc ownership in BRM / Bristol-Myers Squibb Company

On May 28, 2026 - Cozad Asset Management Inc filed a 13F-HR form disclosing ownership of 6,363 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $333,548 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 6,363 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $301,797 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-28 2026-03-31 13F Bristol-Myers Squibb COM 110122108 6,363 0 0.00 386 12.24 0.0303
2026-02-13 2025-12-31 13F Bristol-Myers Squibb COM 110122108 6,363 -169 -2.59 343 16.67 0.0266
2025-11-10 2025-09-30 13F Bristol-Myers Squibb COM 110122108 6,532 0 0.00 295 -2.65 0.0234
2025-08-12 2025-06-30 13F/A-1 Bristol-Myers Squibb COM 110122108 6,532 175 2.75 302 -21.96 0.0264
2025-08-11 2025-06-30 13F Bristol-Myers Squibb COM 110122108 6,357 0 388 0.0387
2025-05-08 2025-03-31 13F Bristol-Myers Squibb COM 110122108 6,357 -50 -0.78 388 6.91 0.0387
2025-02-10 2024-12-31 13F Bristol-Myers Squibb COM 110122108 6,407 435 7.28 362 17.53 0.0338
2024-10-31 2024-09-30 13F Bristol-Myers Squibb COM 110122108 5,972 -116 -1.91 309 22.22 0.0295
2024-08-02 2024-06-30 13F Bristol-Myers Squibb COM 110122108 6,088 -970 -13.74 253 -34.03 0.0252
2024-05-08 2024-03-31 13F Bristol-Myers Squibb COM 110122108 7,058 -855 -10.81 383 -5.91 0.0399
2024-02-05 2023-12-31 13F Bristol-Myers Squibb COM 110122108 7,913 -1,401 -15.04 406 -24.81 0.0468
2023-11-02 2023-09-30 13F Bristol-Myers Squibb COM 110122108 9,314 -601 -6.06 541 -14.83 0.0702
2023-07-26 2023-06-30 13F Bristol-Myers Squibb COM 110122108 9,915 -134 -1.33 634 -8.91 0.0791
2023-05-01 2023-03-31 13F Bristol-Myers Squibb COM 110122108 10,049 239 2.44 696 -1.28 0.0922
2023-02-08 2022-12-31 13F Bristol-Myers Squibb COM 110122108 9,810 1,942 24.68 706 26.12 0.0992
2022-11-07 2022-09-30 13F Bristol-Myers Squibb COM 110122108 7,868 -9 -0.11 559 -7.91 0.0907
2022-08-09 2022-06-30 13F Bristol-Myers Squibb COM 110122108 7,877 23 0.29 607 5.75 0.0946
2022-04-29 2022-03-31 13F Bristol-Myers Squibb COM 110122108 7,854 1,450 22.64 574 43.86 0.0804
2022-02-01 2021-12-31 13F Bristol-Myers Squibb COM 110122108 6,404 -116 -1.78 399 3.37 0.0565
2021-11-05 2021-09-30 13F Bristol-Myers Squibb COM 110122108 6,520 -650 -9.07 386 -19.42 0.0601
2021-07-29 2021-06-30 13F Bristol-Myers Squibb COM 110122108 7,170 -625 -8.02 479 -2.64 0.0752
2021-04-29 2021-03-31 13F Bristol-Myers Squibb COM 110122108 7,795 -763 -8.92 492 -7.34 0.0800
2021-02-16 2020-12-31 13F Bristol-Myers Squibb COM 110122108 8,558 -1,395 -14.02 531 -11.50 0.0949
2020-10-28 2020-09-30 13F Bristol-Myers Squibb COM 110122108 9,953 1 0.01 600 2.56 0.1132
2020-08-07 2020-06-30 13F Bristol-Myers Squibb COM 110122108 9,952 -182 -1.80 585 3.54 0.1189
2020-05-07 2020-03-31 13F Bristol-Myers Squibb COM 110122108 10,134 -200 -1.94 565 -14.78 0.1954
2020-01-16 2019-12-31 13F Bristol-Myers Squibb COM 110122108 10,334 3,644 54.47 663 95.58 0.1769
2019-10-31 2019-09-30 13F Bristol-Myers Squibb COM 110122108 6,690 -5 -0.07 339 11.51 0.0979
2019-08-13 2019-06-30 13F Bristol-Myers Squibb COM 110122108 6,695 -540 -7.46 304 -11.88 0.0881
2019-04-18 2019-03-31 13F Bristol-Myers Squibb COM 110122108 7,235 -485 -6.28 345 -13.97 0.1042
2019-01-14 2018-12-31 13F Bristol-Myers Squibb COM 110122108 7,720 -6,040 -43.90 401 -53.04 0.1385
2018-11-13 2018-09-30 13F Bristol-Myers Squibb COM 110122108 13,760 -224 -1.60 854 10.34 0.2498
2018-08-15 2018-06-30 13F Bristol-Myers Squibb COM 110122108 13,984 13,984 774 0.2408
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.